作者: Bruno Linetzky , Brad Curtis , Gustavo Frechtel , Renan Montenegro , Miguel Escalante Pulido
DOI: 10.1186/S13098-016-0157-1
关键词: In patient 、 Observational study 、 Internal medicine 、 Type 2 Diabetes Mellitus 、 Diabetes mellitus 、 Insulin 、 Latin Americans 、 Type 2 diabetes 、 Baseline data 、 Medicine 、 Endocrinology
摘要: Background Poor glycemic control in patients with type 2 diabetes is commonly recorded worldwide; Latin America (LA) not an exception. Barriers to intensifying insulin therapy and which barriers are most likely negatively impact outcomes completely known. The objective was identify progression individuals mellitus (T2DM) LA countries (Mexico, Brazil, Argentina).